Astonea Labs IPO Listed at a 1.81% premium on BSE at ₹137.45 

Astonea Labs IPO listing gain is 1.81% on BSE, the stock opened at ₹137.45. The IPO GMP was ₹0 last heard.

Astonea Labs IPO subscribed 1.79 times overall on the last day, a retail quota was subscribed over 1.69 times, NII was subscribed over 5.60 times, and QIB was subscribed over 0.70 times. 

Astonea Labs IPO details 

Astonea Labs IPO got approval from SEBI for an IPO of ₹37.67 crores. Astonea Labs IPO consists of a fresh issue of ₹37.67 crores with a face value of ₹10 each. Further, it had a set price band between ₹128 to ₹135 per share. 

In the Astonea Labs  IPO, 1000 shares were in a 1 lot size for the retail minimum and maximum categories. Moreover, 2000 shares were in 2 lot sizes for the S-HNI category. 

To invest in the Astonea Labs IPO, each investor category has specific investment amounts:

  • Retail Investors: Minimum and maximum investment of ₹1,35,000.
  • SHNI (S-HNI): Minimum investment of ₹2,70,000.

Astonea Labs IPO’s Subscription Duration 

Astonea Labs’ IPO subscription started on May 27, 2025, and closed on May 29, 2025. The Astonea Labs IPO allotment date was May 30, 2025, and they received a refund on June 2, 2025. The Astonea Labs IPO listing is on June 3, 2025. 

Astonea Labs’ IPO Funds Deployment 

The funds will be used for various purposes, including covering the costs of registering the business in Bolivia, South America, buying and installing machines for ointment production (for export) on the second floor of the current building as per international standards, promoting and marketing the brand, purchasing necessary hardware and software, meeting working capital needs, and for general business purposes. 

About Astonea Labs IPO Company 

Astonea Labs is one of the trusted manufacturing companies due to 35 years of experience in the industry, based in Haryana, India. Focusing on consumer satisfaction and putting them on top it’s their priority.  

These include tablets, capsules, softgels, powders, ointments, creams, and lotions, all made to meet strict Drug and Cosmetics industry standards. Astonea Labs’ goal is to consistently provide high-quality products that support and improve the lives of people around the world.  

Astonea Labs IPO Company Financial Report

The company reported revenue of ₹80.29 crores in 2024 against ₹67.26 crores in 2023. The company reported a profit of ₹3.81 crores in 2024 against a profit of ₹0.67 crores in 2023.











Share the Post:
Facebook
Twitter
LinkedIn